C16H17N3O5S
Neat
363.39
Cephalexin R-sulfoxide; 52210-38-5; UNII-Z7P5394RKR; Z7P5394RKR; (6R, 7R)-7-((R)-2-Amino-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 5R-oxide; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2R)-2-amino-2-phenylacetyl)amino)-3-methyl-8-oxo-, 5-oxide, (5R, 6R, 7R)-; (5R, 6R, 7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-5, 8-dioxo-5lambda4-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-, 5-oxide, (5R, 6R, 7R)-; Cefalexin Impurity 23; Cephalexin Impurity 42; (5R, 6R and 7R)-7-((R)-2-amino-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 5-oxide
(5R, 6R, 7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-5 and 8-dioxo-5lambda4-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
InChI=1S/C16H17N3O5S/c1-8-7-25(24)15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-,25-/m1/s1